<DOC>
	<DOCNO>NCT02861261</DOCNO>
	<brief_summary>The purpose study conduct multicenter randomize , double-blind , placebo-controlled clinical trial , evaluate effect change gut microbiota berberine and/or probiotic administration patient newly diagnose type 2 diabetes</brief_summary>
	<brief_title>A Study Efficacy Gut Microbiota Berberine Probiotics Patients With Newly Diagnosed Type 2 Diabetes</brief_title>
	<detailed_description>In present study , 400 newly-diagnosed type 2 diabetes patient enrol multiple center China . Randomisation computer generate stratified age . After screen , eligible subject give Gentamycin Sulfate Sustained-release Tablets 80mg bid po week washout period , participant randomly assign one follow four group : Berberine hydrochloride tablets（0.6g bid po）and ProMetS probiotic powder（4g qN po ) , Berberine placebo tablets（6 pill bid po ) ProMetS probiotic powder ( 4g qN po ) , Berberine hydrochloride tablets（0.6g bid po）and Probiotics placebo powder ( 2 strip qN po ) , Berberine placebo tablets（6 pill bid po ) Probiotics placebo powder ( 2 strip qN po ) 3 month . Blood , feces urine sample collect treatment . HbA1C , fast plasma glucose ( FPG ) , postprandial plasma glucose ( PPG ) , GLP-1 , lipid , amino acid , bile acid metabolic related component parameter measure . Furthermore , change gut microbiota evaluate .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<criteria>Main 1 . Newly diagnose type 2 diabetes define WHO ( 1999 ) diagnostic criterion ; Both Genders Eligible ; 2 . Age : ≥20 &lt; 70 year ; 3 . BMI : 19.0 ~ 35.0kg/m2 ; 4 . Not receive previously antidiabetic agent ( oral agent , GLP1 insulin ) ; 5 . Have least 2 month life style intervention control blood glucose screening ; 6 . HbA1c ≥6.5 % ≤10.0 % , fast plasma glucose≥7.0 mmol/L ≤13.3mmol/L screening . Details please see study protocol . Main 1 . Significant impaired liver function ( defined alanine transaminase ( ALT ) &gt; 2.5 time upper limit normal ) ; Impaired renal function ( defined serumcreatinine &gt; 132μmol/L eGFR &lt; 60 mL/min/1.73m2 ) ; Mental disease , severe infection , severe anemia , neutropenia disease ; 2 . Other severe heart disease , congenital heart disease , rheumatic heart disease , hypertrophic dilate cardiomyopathy , define New York Heart Association class III IV ; 3 . Allergic gentamicin amino glycoside antibiotic ; 4 . Histories acute diabetic complication include diabetic ketoacidosis hyperosmolar hyperglycemic nonketotic coma within 3 month ; 5 . Pregnancy ; 6 . Acute chronic diarrhea severe constipation digestive tract disease ; 7 . Medical history malignant tumor ( except local skin basal cell carcinoma ) past 5 year ; 8 . Medical history intestine , digestive tract surgery ( cholecystectomy ) within one year , non gastrointestinal surgery within 6 month . Details please see study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>